"Libido Remains Untouched"... Potential Confirmed for Male Contraception That Halts Only Sperm Production
Blocking Only Sperm Production Without Affecting Hormones
Recovery Confirmed Within Six Weeks After Discontinuation
Effectiveness Demonstrated in Mice... Further Research Needed for Commercialization
A male contraceptive technology that can temporarily halt sperm production without surgery or hormonal manipulation has demonstrated effectiveness in animal experiments. Although still in the early stages, it is drawing attention for its ability to selectively stop and then restore sperm production without side effects.
A research team at Cornell University in the United States announced the results of a study that demonstrated a contraceptive mechanism capable of temporarily stopping sperm production and subsequently restoring it to normal without affecting the hormonal system. The study results were published in the Proceedings of the National Academy of Sciences (PNAS) on April 7 (local time).
The research team confirmed the possibility of selectively inhibiting a specific stage in the process of sperm formation, allowing sperm production to be temporarily halted for a certain period.
Currently, male contraceptive methods are mainly limited to condoms and vasectomy, but these have drawbacks such as inconvenience or difficulty in reversal. Additionally, the development of male birth control pills has been delayed due to concerns about hormonal side effects. Lowering testosterone levels artificially can lead to a decline in libido and thus a reduction in quality of life. For this reason, “reversible non-hormonal contraception”—which works for a certain period without surgery and is restored after discontinuation—has long been a sought-after goal.
The research team focused on the process of “meiosis,” during which sperm cells are produced, rather than on hormones. By using a small molecule compound called JQ1 to inhibit the activity of a specific protein complex essential for sperm formation, the maturation of sperm is prevented. The key is to temporarily halt only a selected part of the sperm production process without affecting the body’s overall hormonal system.
In animal experiments, male mice administered the drug did not cause pregnancy even after mating with female mice, confirming the contraceptive effect. When the administration of the drug was stopped, normal sperm production resumed after about six weeks. The offspring born afterwards showed no abnormalities, and the next generation’s reproductive ability was also unaffected, according to the research team.
Professor Paula Cohen, who led the research, explained, “This demonstrates the possibility for men to control their own fertility by selectively blocking only a specific stage of sperm production,” and described it as “a new approach to contraception without hormonal side effects.” The team is considering the possibility of developing this technology in various forms, such as an injectable or a skin patch, in the future.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
However, as this study is an early-stage experiment conducted on animals, further research and clinical trials are needed before the same effects and safety can be confirmed in humans. Based on these results, the research team aims to establish a company to commercialize the technology and begin human clinical trials within two years.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.